QUIDELORTHO CORP Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
QUIDELORTHO CORP (QDEL) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $42.60 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2026-02-19
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2025-03-30 was $19.20M, a 64.10% increase year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-12-29 was -$25.50M, a 180.19% decline year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-09-29 was $31.20M.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-06-30 was $10.70M, a 77.38% decline year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for fiscal 2025 was $42.60M, a 51.60% increase from fiscal 2024.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for fiscal 2024 was $28.10M, a 55.04% decline from fiscal 2023.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for fiscal 2023 was $62.50M.
- QUIDELORTHO CORP other comprehensive income (loss), before reclassifications, net of tax for fiscal 2023 was -$62.80M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-28 | $42.60M 10-K · filed 2026-02-19 | |||||
| 2025-03-30 | $19.20M 10-Q · filed 2025-05-08 | -$6.30M derived: sum of 2 quarters · filed 2026-02-19 | $24.90M derived: sum of 3 quarters · filed 2026-02-19 | $35.60M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-12-29 | -$25.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.70M derived: sum of 2 quarters · filed 2026-02-19 | $16.40M derived: sum of 3 quarters · filed 2026-02-19 | $28.10M 10-K · filed 2026-02-19 | ||
| 2024-09-29 | $31.20M 10-Q · filed 2024-11-08 | $41.90M derived: sum of 2 quarters · filed 2024-11-08 | $53.60M 10-Q · filed 2024-11-08 | $85.40M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-06-30 | $10.70M 10-Q · filed 2024-08-01 | $22.40M 10-Q · filed 2024-08-01 | $54.20M derived: sum of 3 quarters · filed 2026-02-19 | $23.60M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-03-31 | $11.70M 10-Q · filed 2025-05-08 | $9.70M 10-Q · filed 2024-05-09 | $43.50M derived: sum of 2 quarters · filed 2026-02-19 | $12.90M derived: sum of 3 quarters · filed 2026-02-19 | $60.20M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | $31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.20M derived: sum of 2 quarters · filed 2026-02-19 | $48.50M derived: sum of 3 quarters · filed 2026-02-19 | $62.50M 10-K · filed 2026-02-19 | $61.50M 10-K · filed 2024-02-29 | |
| 2023-10-01 | -$30.60M 10-Q · filed 2024-11-08 | $16.70M derived: sum of 2 quarters · filed 2024-11-08 | $30.70M 10-Q · filed 2024-11-08 | $113.50M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-07-02 | $47.30M 10-Q · filed 2024-08-01 | $61.30M 10-Q · filed 2024-08-01 | $144.10M derived: sum of 3 quarters · filed 2025-02-27 | $60.50M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-04-02 | $14.00M 10-Q · filed 2024-05-09 | $96.80M derived: sum of 2 quarters · filed 2025-02-27 | $13.20M derived: sum of 3 quarters · filed 2025-02-27 | -$48.70M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-01-01 | $82.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$800.00K derived: sum of 2 quarters · filed 2025-02-27 | -$62.70M derived: sum of 3 quarters · filed 2025-02-27 | -$62.80M 10-K · filed 2025-02-27 | ||
| 2022-10-02 | -$83.60M 10-Q · filed 2023-11-02 | -$145.50M derived: sum of 2 quarters · filed 2023-11-02 | -$145.60M 10-Q · filed 2023-11-02 | |||
| 2022-07-03 | -$61.90M 10-Q · filed 2023-08-09 | -$62.00M 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |